These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26968760)

  • 1. Natural product derived immune-regulatory agents.
    Talmadge JE
    Int Immunopharmacol; 2016 Aug; 37():5-15. PubMed ID: 26968760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products and their derivatives: Promising modulators of tumor immunotherapy.
    Deng LJ; Qi M; Li N; Lei YH; Zhang DM; Chen JX
    J Leukoc Biol; 2020 Aug; 108(2):493-508. PubMed ID: 32678943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy for infectious diseases: challenges and prospects].
    Karaulov AV; Kaliuzhin OV
    Ter Arkh; 2013; 85(11):100-8. PubMed ID: 24432609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries.
    Pérez Del Palacio J; Díaz C; de la Cruz M; Annang F; Martín J; Pérez-Victoria I; González-Menéndez V; de Pedro N; Tormo JR; Algieri F; Rodriguez-Nogales A; Rodríguez-Cabezas ME; Reyes F; Genilloud O; Vicente F; Gálvez J
    J Biomol Screen; 2016 Jul; 21(6):567-78. PubMed ID: 26962874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic response modifiers: Indications, implications, and insights.
    Davis BP; Ballas ZK
    J Allergy Clin Immunol; 2017 May; 139(5):1445-1456. PubMed ID: 28263774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally occurring immunomodulators with antitumor activity: An insight on their mechanisms of action.
    Mohamed SIA; Jantan I; Haque MA
    Int Immunopharmacol; 2017 Sep; 50():291-304. PubMed ID: 28734166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of microbial proteasome inhibitors.
    Momose I; Kawada M
    Int Immunopharmacol; 2016 Aug; 37():23-30. PubMed ID: 26589840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers.
    Buchwald UK; Pirofski L
    Curr Pharm Des; 2003; 9(12):945-68. PubMed ID: 12678861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Toll-like receptor signaling in innate immunity by natural products.
    Chen L; Yu J
    Int Immunopharmacol; 2016 Aug; 37():65-70. PubMed ID: 26899347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of natural products with cell survival and signaling pathways in the biochemical elucidation of drug targets in cancer.
    Qurishi Y; Hamid A; Majeed R; Hussain A; Qazi AK; Ahmed M; Zargar MA; Singh SK; Saxena AK
    Future Oncol; 2011 Aug; 7(8):1007-21. PubMed ID: 21823895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oceans as a Source of Immunotherapy.
    Ahmad B; Shah M; Choi S
    Mar Drugs; 2019 May; 17(5):. PubMed ID: 31083446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse model-based screening platform for the identification of immune activating compounds such as natural products for novel cancer immunotherapies.
    Richter L; Kropp S; Proksch P; Scheu S
    Bioorg Med Chem; 2019 Dec; 27(23):115145. PubMed ID: 31648874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural products in drug discovery: advances and opportunities.
    Atanasov AG; Zotchev SB; Dirsch VM; ; Supuran CT
    Nat Rev Drug Discov; 2021 Mar; 20(3):200-216. PubMed ID: 33510482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Drugs from bugs': bacterial effector proteins as promising biological (immune-) therapeutics.
    Rüter C; Hardwidge PR
    FEMS Microbiol Lett; 2014 Feb; 351(2):126-32. PubMed ID: 24261744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological response modifiers: current use and future prospects in cancer therapy.
    Bisht M; Bist SS; Dhasmana DC
    Indian J Cancer; 2010; 47(4):443-51. PubMed ID: 21131760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial overview: Immunomodulation: Striking the right balance: using immunomodulators to target infectious diseases, cancer, and autoimmunity.
    Lavelle EC; McLachlan JB
    Curr Opin Pharmacol; 2018 Aug; 41():vii-ix. PubMed ID: 30139514
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological agents in treatment of cancer.
    Hersey P
    Aust N Z J Med; 1990 Feb; 20(1):85-98. PubMed ID: 2181990
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunomodulatory approaches for prevention and treatment of infectious diseases.
    Nijnik A
    Curr Opin Microbiol; 2013 Oct; 16(5):590-5. PubMed ID: 23870826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologics for the treatment of autoimmune renal diseases.
    Holdsworth SR; Gan PY; Kitching AR
    Nat Rev Nephrol; 2016 Apr; 12(4):217-31. PubMed ID: 26949177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.